MedTrace Logo

Low Sirtuin-1 Levels Are Linked to Erythropoietin Resistance in Hemodialysis Patients.

NCT06877286 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 391

Last updated 2025-03-19

No results posted yet for this study

Summary

This study investigates the relationship between Sirtuin-1 (SIRT1) levels and erythropoietin resistance in hemodialysis patients. The study aims to determine whether low SIRT1 levels contribute to EPO resistance and to explore the potential mechanisms involved. Blood samples and clinical data from hemodialysis patients will be analyzed to evaluate this relationship.

Conditions

Interventions

DIAGNOSTIC_TEST

Sirtuin-1 Level Measurement

Measurement of serum Sirtuin-1 levels using ELISA in hemodialysis patients to evaluate the relationship between Sirtuin-1 levels and erythropoietin resistance

Sponsors & Collaborators

  • Bursa Yuksek Ihtisas Training and Research Hospital

    collaborator OTHER_GOV

  • Cuma Bulent Gul

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2021-03-30
Completion
2021-10-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06877286 on ClinicalTrials.gov